Vera Therapeutics, Inc. (VERA) Social Stream
VERA THERAPEUTICS INC (VERA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VERA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-17 | 3 | $28 | $24 | $26 | $15.53 | 67.42% |
| 2021-12-06 | 3 | $35 | $24 | $29.5 | $15.53 | 89.95% |
| 2022-03-25 | 4 | $36 | $24 | $30 | $15.53 | 93.17% |
| 2022-03-28 | 5 | $36 | $24 | $31.666 | $15.53 | 103.9% |
| 2022-04-19 | 5 | $36 | $24 | $31.75 | $15.53 | 104.44% |
| 2022-05-03 | 6 | $36 | $24 | $31.75 | $15.53 | 104.44% |
| 2022-05-17 | 6 | $36 | $24 | $32.4 | $15.53 | 108.63% |
| 2022-05-26 | 6 | $35 | $24 | $32.2 | $15.53 | 107.34% |
| 2022-06-06 | 5 | $35 | $32 | $34.25 | $15.53 | 120.54% |
| 2022-07-12 | 6 | $35 | $32 | $34.4 | $15.53 | 121.51% |
| 2022-08-11 | 6 | $35 | $33 | $34.4 | $15.53 | 121.51% |
| 2022-11-07 | 6 | $36 | $33 | $34.6 | $15.53 | 122.79% |
| 2022-11-10 | 6 | $36 | $32 | $34.2 | $15.53 | 120.22% |
| 2022-11-29 | 6 | $38 | $32 | $34.8 | $15.53 | 124.08% |
| 2023-03-28 | 6 | $38 | $6 | $17 | $15.53 | 9.47% |
| 2023-03-29 | 6 | $38 | $6 | $16 | $15.53 | 3.03% |
| 2023-05-11 | 6 | $22 | $6 | $12.8 | $15.53 | -17.58% |
| 2023-05-12 | 6 | $22 | $7 | $13.2 | $15.53 | -15% |
| 2023-05-17 | 6 | $23 | $7 | $13.4 | $15.53 | -13.72% |
| 2023-08-10 | 6 | $24 | $7 | $15.2 | $15.53 | -2.12% |
| 2023-08-11 | 7 | $24 | $10 | $18.25 | $15.53 | 17.51% |
| 2023-08-16 | 7 | $27 | $10 | $19.666 | $15.53 | 26.63% |
| 2023-09-13 | 7 | $27 | $10 | $20 | $15.53 | 28.78% |
| 2023-11-05 | 7 | $27 | $16 | $22.5 | $15.53 | 44.88% |
| 2023-11-10 | 7 | $27 | $16 | $22.5 | $15.53 | 44.88% |
| 2023-11-13 | 7 | $27 | $16 | $23.833 | $15.53 | 53.46% |
| 2023-11-30 | 7 | $27 | $16 | $23.333 | $15.53 | 50.24% |
| 2023-12-18 | 8 | $29 | $16 | $24.142 | $15.53 | 55.45% |
The Trend in the Analyst Price Target
Over the past 16 months, VERA's average price target has gone down $10.26.
Over the past 38 weeks, VERA's average upside potential has been 51.4%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-28 | 6 | 38 | 6 | 17.000 | 7.26 | 134.16% |
| 2023-04-12 | 6 | 22 | 6 | 12.800 | 6.23 | 105.46% |
| 2023-08-11 | 6 | 24 | 7 | 16.000 | 18.47 | -13.37% |
| 2023-09-13 | 7 | 27 | 10 | 20.000 | 16.84 | 18.76% |
| 2023-12-18 | 8 | 29 | 16 | 24.142 | 15.64 | 54.36% |
VERA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 6 | 1 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
VERA's average broker recommendation rating worsened by 0.38 over the prior 13 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- VERA THERAPEUTICS INC's variance in analysts' estimates is lower than -1495.79% of all US stocks.
- In terms of how VERA THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1851.58% of that group.
- In the context of all US stocks, VERA THERAPEUTICS INC's number of analysts covering the stock is greater than 807.75% of them.
- VERA THERAPEUTICS INC's average analyst price target is higher than 1895.14% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VERA THERAPEUTICS INC are DAWN, CNTA, and ALZN.
View All Top Stocks by Price Target
Make investment decisions regarding VERA using the data that counts. Try POWR Ratings for free.